Skip to content

Clinical trials

Completed Observational Multiple Endocrine Neoplasia Type 1 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Phase: Observational Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20092
20133
20141
20161
20181
20191
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Ghent2
Centre Hospitalier Universitaire, Amiens1
Charite University, Berlin, Germany1
Federal University of São Paulo1
Freeman-Sheldon Research Group, Inc.1
Jersey Shore University Medical Center1
M.D. Anderson Cancer Center1
National University Health System, Singapore1
Novartis Pharmaceuticals1
Ohio State University Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 115
Anxiety Disorders1
Breast Neoplasms1
Coronary Stenosis1
Major Depressive Disorder1
Multiple Endocrine Neoplasia1
Muscular Atrophy1
Muscular Diseases1
Myalgia1
Neoplasm Metastasis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.